Zhejiang Ausun Pharmaceutical Co., Ltd.
Zhejiang Aoxiang Pharmaceutical Co., Ltd. is engaged in the research and development, production and sales of pharmaceutical preparations, specialty APIs and key pharmaceutical intermediates.
Zhejiang Aoxiang Pharmaceutical Co., Ltd. is mainly engaged in the research and development, production, and sales of pharmaceutical preparations, specialty APIs, and key pharmaceutical intermediates, as well as providing customized processing and research and development services to customers;
- Type
- Manufacturer
- Location
- Zhejiang, China
- Website
- https://www.ausunpharm.com
- Categories
- 药品制造, 化学品与塑料, 医疗保健用品
Listed in a source registry
Verified facts
- sanctions-clear (green), checked 2026-08-04 OpenSanctions
- debarment-clear (green), checked 2026-08-04 OpenSanctions
- web-presence-since (green), checked 2026-08-03 Internet Archive (Wayback)
- lei-lapsed (amber), checked 2026-08-04 GLEIF
- domain-registered (green), checked 2026-08-04 Domain registry record
- corporate-mail-on-domain (green), checked 2026-08-04 Mail server of the company domain
- gmp-certified (green), checked 2024-01-11 EudraGMDP, EU register of GMP certificates (EMA)
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)
- Chemical substances imported into the EU above 1 tonne/year must be REACH-registered. ECHA (REACH)
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)